Stem cells hold remarkable potential for modern medicine.
Monash scientists are searching for new treatments for disease through better understanding the role stem cells and tissue repair mechanisms play in our bodies.
The unique partnership between our School of Biomedical Sciences, the Australian Regenerative Medicine Institute and the Monash Institute of Medical Research leaves us poised to deliver the next generation of discoveries in regenerative medicine and cell-based therapy.
We have been able to generate stem cells from patients with kidney disease, Friedreich's ataxia and multiple sclerosis. We lead discoveries in tissue development and repair after injury and we are finding new ways to boost the body's regenerative ability by investigating how systems are regulated at a molecular level.
We are conducting research using a range of stem cell types, including:
- pluripotent embryonic cells
- induced pluripotent cells
- adult stem cells.
Our researchers and industry partners have access to powerful facilities, including:
- Australian Regenerative Medicine Institute
- Monash Micro Imaging
- ARMI Gene Recombineering Facility
- MIMR Next Gen sequencing
Working with industry
Our structure, facilities and partnerships improve the quality and scope of our research, while producing opportunities for spin-off companies, medical discoveries and improved access to commercial and intellectual ownership.
New therapies are being developed for leukemia at The Alfred Hospital and for solid tumours at Monash Health Translation Precinct.
And the Monash Institute of Medical Research is at the forefront of clinical translation of cell based therapies.
Our partners include:
- Mesoblast Ltd
- Cell Care Australia
- Stem Cells Australia
- European Molecular Biology Laboratory
- Californian Institute of Regenerative Medicine - San Francisco
- Australia-China Centre for Excellence in Stem Cells - University of Peking
- Stem Cell Network Asia Pacific
- Immune regeneration
- Embryonic stem cell differentiation
- Renal regeneration
- GMP based cell isolation and production